Terry Pizzie

Terry Pizzie is a Non-Executive Director at Newcells Biotech Ltd with an extensive career in the life science industry spanning over 30 years.1 His experience and expertise make him a valuable addition to the company's board.

Career Highlights

Terry Pizzie has held several significant positions throughout his career:

1. CEO of Horizon Discovery Plc: He led this Cambridge-based public company listed on the UK AIM market, overseeing its growth until its acquisition by Perkin Elmer Corp.1

2. CEO of Astrea Bioseparations: This is his current role, where he brings his extensive experience in the biotech tools sector.4

3. VP Global Sales at Pacific Biosciences: He held a senior commercial position at this biotechnology company.1

4. Leadership roles at Genetix PLC and Biacore: He worked at Genetix PLC (acquired by Danaher Corp) and the Swedish biotech company Biacore (acquired by GE).1

5. VP Europe at Applied Biosystems: This is where Terry started his career in the life science sector, eventually rising to a vice president position.1

Education

Terry Pizzie graduated with a degree in Physiology and Biochemistry from Reading University.1

Expertise

With his extensive background in the biotechnology and life sciences sectors, Terry brings valuable commercial and operational experience to Newcells Biotech.5 His expertise spans various areas, including:

• Leadership and management in biotech companies
• Commercial strategy and global sales
• Mergers and acquisitions
• Drug discovery and development

Terry Pizzie joined the Board of Newcells Biotech as a non-executive director in November 2023, contributing his wealth of experience to the company's continued growth and development.23